Please provide your email address to receive an email when new articles are posted on . Levonorgestrel-releasing intrauterine system users vs. nonusers had an increased risk for breast cancer. Breast ...
The study was a multicentre, double-blind, randomised, placebo-controlled trial of mepivacaine (10 mL of 20 mg/mL) vs placebo (0.9 mg/mL sodium chloride) instilled into the uterus 2 minutes before IUD ...
The FDA gave premarket approval to the first medical device for the treatment of women with symptomatic moderate-to-severe intrauterine adhesions, known as Asherman syndrome, maker Womed announced on ...
Please provide your email address to receive an email when new articles are posted on . Treatment success for the JADA system was high for both vaginal and cesarean births. Overall, 2.8% of women in ...
'rendered': 'In a move to reduce maternal mortality in the country, DKT International Nigeria has expanded access to modern contraceptive options with the launch of Avibela, a long-acting hormonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results